全文获取类型
收费全文 | 1399119篇 |
免费 | 99740篇 |
国内免费 | 7717篇 |
专业分类
耳鼻咽喉 | 20319篇 |
儿科学 | 40912篇 |
妇产科学 | 39251篇 |
基础医学 | 194503篇 |
口腔科学 | 40848篇 |
临床医学 | 121000篇 |
内科学 | 271640篇 |
皮肤病学 | 30759篇 |
神经病学 | 109779篇 |
特种医学 | 56119篇 |
外国民族医学 | 469篇 |
外科学 | 214786篇 |
综合类 | 42028篇 |
现状与发展 | 22篇 |
一般理论 | 437篇 |
预防医学 | 96394篇 |
眼科学 | 33193篇 |
药学 | 106654篇 |
58篇 | |
中国医学 | 6291篇 |
肿瘤学 | 81114篇 |
出版年
2018年 | 13975篇 |
2017年 | 11574篇 |
2016年 | 12468篇 |
2015年 | 14893篇 |
2014年 | 20320篇 |
2013年 | 28299篇 |
2012年 | 37799篇 |
2011年 | 40156篇 |
2010年 | 24155篇 |
2009年 | 22747篇 |
2008年 | 36750篇 |
2007年 | 40008篇 |
2006年 | 40483篇 |
2005年 | 39378篇 |
2004年 | 37212篇 |
2003年 | 36096篇 |
2002年 | 35290篇 |
2001年 | 64836篇 |
2000年 | 66717篇 |
1999年 | 56848篇 |
1998年 | 15680篇 |
1997年 | 14414篇 |
1996年 | 13666篇 |
1995年 | 12911篇 |
1994年 | 12128篇 |
1992年 | 43166篇 |
1991年 | 41645篇 |
1990年 | 40874篇 |
1989年 | 39826篇 |
1988年 | 37171篇 |
1987年 | 36600篇 |
1986年 | 35042篇 |
1985年 | 33194篇 |
1984年 | 24874篇 |
1983年 | 21101篇 |
1982年 | 12697篇 |
1981年 | 11593篇 |
1979年 | 23944篇 |
1978年 | 17071篇 |
1977年 | 14837篇 |
1976年 | 13388篇 |
1975年 | 15270篇 |
1974年 | 18080篇 |
1973年 | 17567篇 |
1972年 | 16810篇 |
1971年 | 15717篇 |
1970年 | 14914篇 |
1969年 | 14347篇 |
1968年 | 13461篇 |
1967年 | 12015篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
991.
K S McGrew R F Ittenbach R H Bruininks B K Hill 《Research in developmental disabilities》1991,12(2):181-199
Data obtained on a sample of persons with mild to profound degrees of mental retardation (N = 8255) and ranging from birth to 98 years of age were factor analyzed to provide information on the structure of maladaptive behavior relative to age and degree of mental retardation. Using the Problem Behavior scales of the Inventory for Client and Agency Planning, two principal factors emerged for children with mild to profound degrees of retardation: Internalized Maladaptive and Externalized Maladaptive. For adolescents and young adults, a three-factor solution which varied by degree of retardation was most appropriate. For middle and older adults, three- and four-factor solutions were identified across all ages and degrees of retardation. Across all samples as many as six different types of dimensions were identified, indicating that the structure of maladaptive behavior may well be influenced by age and level of mental retardation. 相似文献
992.
Spindles are a ubiquitous phenomenon in sleep, but their physiology and the effects of neurologic disorder on their frequency and amplitude are incompletely understood. We compared the incidence of three commonly defined spindle types (14-15 Hz, 12-13 Hz, and 10 Hz) and the frequency and amplitude of spindles during Stage II sleep in 50 patients with complex partial, partial and secondarily generalized, and primary generalized seizures, with and without interictal behavioral symptoms. All patients had 12-13 Hz and 14-15 Hz spindles of symmetric character in C3-A1 and C4-A2 derivations during prolonged sleep-deprived EEG recordings, which were normal except for partial or generalized epileptiform activity. Seventy-one per cent of complex partial seizure patients had 10 Hz spindles, and they occurred in 50% of the other two groups, predominating among those with interictal behavioral symptoms in all groups. Spindle frequency was significantly less in patients with generalized epilepsy than with partial seizures, and patients with complex partial seizures and partial seizures with secondary generalization differed significantly in spindle frequency. Spindle frequency was significantly lower with polypharmacy than with monotherapy. Patients whose regimens included phenobarbital had significantly lower spindle frequencies and spindle frequencies differed significantly between phenytoin and carbamazepine. Differences in spindle frequency may be due to residual medication effects, underlying encephalopathy or physiological differences between partial and generalized epilepsy. 相似文献
993.
H Seigel 《Journal of continuing education in nursing》1991,22(4):147-151
The many challenges facing nursing educators today include meeting the regulatory agency education standards while reaching staff on a variety of shifts/schedules. This article describes a model for the development, implementation, and evaluation of required inservice education that meets this challenge. Creative teaching strategies are discussed that facilitate learning at the individual level, encourage staff participation at the unit level, and contain costs at the department level. 相似文献
994.
995.
The Barnes Hospital Apheresis Blood Collection and Blood Transfusion Unit is part of Barns Hospital Blood Bank. Because of its size and complexity, we report our experience which may be useful to administrators and physicians involved in the planning or management of similar services. From 1985 through 1988 we collected platelets from 1,976 different donors, the majority of which (87%) were community donors. Sixty-nine percent of 1,976 donors donated in 1988 an average of 4.9 times. Of 6,568 apheresis products collected. 1.1% were discarded because of positive screening tests and 0.7% were discarded because of outdating or presence of fibrin clot. In 1988 a total of nine cell separators were used. All donor apheresis were done with seven blood separators, and on average a separator produced an apheresis product every 4.5 worked hours. All therapeutic apheresis (338) were done on two separators. Most of them (88%) were performed during work hours. In 1988 donor and therapeutic apheresis were done by 17 1/2 full-time employees (FTEs) during work hours. Considering the Workload Unit Value per procedure given by the College of American Pathologists (CAP) and that each FTE worked 1,864 hours per year, the worked hour productivity for donor and therapeutic apheresis was 78.2%. Blood collections, therapeutic bleeds, and outpatient transfusions (1,127, 114 and 1,745 respectively) were accomplished by two FTEs, for a worked hour productivity of 35.5%. Because 95.1% of total worked units was produced by efficient donor and therapeutic apheresis activities, overall efficiency remained high at 73.8%. 相似文献
996.
997.
G Hochhaus H Derendorf H M?llmann J Barth 《Journal of pharmaceutical and biomedical analysis》1991,9(9):761-767
A combined LC/RIA procedure is described for the selective determination of dexamethasone (DEX) and its prodrug dexamethasone-21-isonicotinate (DIN) in plasma. The low affinity of the employed dexamethasone antiserum for DIN (cross-reactivity less than 0.5%) allowed the direct determination of DEX in plasma extracts. For the determination of DIN, both substances of interest were separated by LC, the DIN containing fraction was collected, hydrolysed and the generated DEX was consequently assayed by radioimmunoassay. The assay detection limits were 0.1 ng ml-1 for DEX and 0.75 ng ml-1 for DIN. For both substances, inter- and intra-day variabilities (RSDs) were 6 and 12%, respectively. 相似文献
998.
Jeffery H Wootton Anthony B Ross Chris J Diederich 《International journal of hyperthermia》2007,23(8):609-622
PURPOSE: This study was designed to assess pelvic bone temperature during typical treatment regimens of transurethral ultrasound thermal ablation of the prostate to establish guidelines for limiting bone heating. METHODS: Treatment with transurethral planar, curvilinear, and sectored tubular applicators was simulated using an acoustic and biothermal pelvic model that accommodates applicator sweeping, boundary temperature control, and changes in perfusion and attenuation with thermal dose to more accurately model ultrasound energy penetration. The effects of various parameters including power and frequency (5-10 MHz) on bone heating were assessed for a range of prostate cross-sections (3-5 cm) and bone distances (1-3 cm). RESULTS: All devices can produce significant bone heating (temperatures >50 degrees C, thermal dose >240 EM(43 degrees C)) without optimization of applied frequency or power for bone <3 cm from the prostate boundary. In small glands ( approximately 3 cm) increasing operating frequency of curvilinear and planar devices can increase bone temperatures, whereas the tubular applicator can be used at 10 MHz to avoid likely bone damage. In larger prostates (4-5 cm wide) increasing frequency reduces bone heating but can substantially increase treatment time. Lowering power can reduce bone temperature but may increase thermal dose by increasing treatment duration. All applicators can be used to treat glands 4-5 cm with limited bone heating by selecting appropriate power and frequency. CONCLUSIONS: Pubic bone heating during ultrasound thermal therapy of the prostate can be substantial in certain situations. Successful realization of this therapy will require patient-specific treatment planning to optimally determine power and frequency in order to minimize bone heating. 相似文献
999.
Najat C Daw Wayne L Furman Clinton F Stewart Lisa C Iacono Mark Krailo Mark L Bernstein Janet E Dancey Rose Anne Speights Susan M Blaney James M Croop Gregory H Reaman Peter C Adamson 《Journal of clinical oncology》2005,23(25):6172-6180
PURPOSE: Epidermal growth factor receptor is expressed in pediatric malignant solid tumors. We conducted a phase I trial of gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, in children with refractory solid tumors. PATIENTS AND METHODS: Gefitinib (150, 300, 400, or 500 mg/m2) was administered orally to cohorts of three to six patients once daily continuously until disease progression or significant toxicity. Pharmacokinetic studies were performed during course one (day 1 through 28). RESULTS: Of the 25 enrolled patients, 19 (median age, 15 years) were fully evaluable for toxicity and received 54 courses. Dose-limiting toxicity was rash in two patients treated with 500 mg/m2 and elevated ALT and AST in one patient treated with 400 mg/m2. The maximum-tolerated dose was 400 mg/m2/d. The most frequent non-dose-limiting toxicities were grade 1 or 2 dry skin, anemia, diarrhea, nausea, and vomiting. One patient with Ewing's sarcoma had a partial response. Disease stabilized for 8 to > or = 60 weeks in two patients with Wilms' tumor and two with brainstem glioma (one exophytic). At 400 mg/m2, the median peak gefitinib plasma concentration was 2.2 microg/mL (range, 1.2 to 3.6 microg/mL) and occurred at a median of 2.3 hours (range, 2.0 to 8.3 hours) after drug administration. The median apparent clearance and median half-life were 14.8 L/h/m2 (range, 3.8 to 24.8 L/h/m2) and 11.7 hours (range, 5.6 to 22.8 hours), respectively. Gefitinib systemic exposures were comparable with those associated with antitumor activity in adults. CONCLUSION: Oral gefitinib is well tolerated in children. Development of the drug in combination with cytotoxic chemotherapy will be pursued. 相似文献
1000.
A case of esthesioneuroblastoma with an unusual clinical and radiographic presentation is reported. The presenting symptoms as well as the computed tomographic examination were compatible with a primary intracranial mass. 相似文献